Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Biomedicines|February 25, 2023
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for PhysiciansAnnalisa Cespiati, Felice Cinque, Marica Meroni, et al.
International Journal of Molecular Sciences|March 10, 2022
PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced DiseaseRosa Lombardi, Roberto Piciotti, Paola Dongiovanni, et al.
International Journal of Molecular Sciences|August 29, 2024
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined ApplicationMiriam Longo, Erika Paolini, Pietro Di Benedetto, et al.
International Journal of Molecular Sciences|February 13, 2026
The I148M PNPLA3 Variant Forces Progressive Portal MASLD by Spatially Perturbing Metabolic Pathways Across Liver ZonesErika Paolini, Marica Meroni, Miriam Longo, et al.
Antioxidants (Basel, Switzerland)|June 26, 2025
A Defective Circulating Mitochondrial Bioenergetics Profile Reflects the Hepatic One and Outlines Genetic MASLDErika Paolini, Miriam Longo, Marica Meroni, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept StudyMiriam Longo, Erika Paolini, Marica Meroni, et al.
Frontiers in Nutrition|October 3, 2022
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemiaMarica Meroni, Miriam Longo, Erika Paolini, et al.
Iscience|October 6, 2025
Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN miceMarica Meroni, Erika Paolini, Miriam Longo, et al.
Pageof 8